Funding opportunities for COVID-19 research available to investigators

Research Development and the Research Concierge Service at Penn State College of Medicine have developed a list of funding opportunities for investigators interested in research projects related to COVID-19.

April 10, 2021Penn State College of Medicine News

The National Science Foundation, National Institutes of Health, Centers for Disease Control and other institutions are supporting research from a variety of disciplines to address the COVID-19 pandemic.

Note regarding human subjects research

In order to reduce any additional personal contact between individuals, certain guidelines are in place for clinical research. See details on the University's requirements for human subjects research here.

University funding

• Added April 7, 2020: Institute for Computational and Data Sciences' Explore Grants - note that this opportunity focuses on supporting Penn State researchers using Penn State's supercomputing system (ICDS-ACI), collaboration with the ICDS RISE team of computational experts and assistance accessing the rapidly growing stores of COVID-19 data beyond Penn State (rolling deadline)

Department of Defense

Department of Health and Human Services

National Institutes of Health (NIH)

• NEWAdded April 13, 2021: RFA-AG-21-035 Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) (letter of intent deadline May 9, 2021)
• Added April 8, 2021: NOT-OD-21-064 Notice of Intent to Publish Funding Opportunity Announcements for the RADx-UP Initiative (Phase II) (deadline April 30, 2021) Notes: The National Institutes of Health (NIH) is issuing this Notice to alert the community about four upcoming Funding Opportunity Announcements (FOAs) as part of the Rapid Acceleration of Diagnostics for Underserved Populations (RADx-UP) initiative to solicit intervention research on COVID-19 diagnostic testing among underserved and vulnerable populations. The FOAs are expected to be published in April, and NIH acceptance of applications will depend on the time frame outlined in each opportunity announcement, but will be no later than July 31. The FOAs will include two Requests for Applications (RFAs) and two Notices of Special Interest (NOSIs). The goal is to make awards as early as October 2021.
• Added April 8, 2021: PAR-21-213 Emergency Award: Social, Behavioral, and Economic Research on COVID-19 Consortium (U01 Clinical Trial Not Allowed) (deadlines June 9 and Nov. 8, 2021)
• Added March 23, 2020: RFA-AI-20-028 Partnerships for Countermeasures against Select Pathogens (R01 Clinical Trials Not Allowed)
• Added March 15, 2021: NOT-GM-21-032 Notice of Special Interest (NOSI): Administrative Supplements to SEPA Awards to Develop Innovative Educational Resources to Address SARS-CoV-2 Vaccine Hesitancy (deadline April 30, 2021)
• Added March 3, 2021: NOT-AG-21-016 Notice of Special Interest (NOSI): Neurological and Neurocognitive Sequelae from SARS-CoV-2 Infection and COVID-19 in Aging and Age-Related Neurodegeneration (rolling deadlines from June 5, 2021, to May 8, 2023)
• Added March 3, 2021: NOT-GM-21-019 Notice of Special Interest (NOSI): Availability of Urgent Competitive Revisions for Modeling Research on Coronavirus Disease 2019 (COVID-19) and the Causative Virus SARS-CoV-2 (rolling deadlines through Dec. 16, 2021)
• Added Feb. 19, 2021: Notice of Special Interest (NOSI) - NOT-AG-21-015: Aging-Relevant Behavioral and Social Research on Coronavirus Disease 2019 (COVID-19) (deadline May 8, 2023)
• Added Feb. 19, 2021: Notice of Special Interest (NOSI) - NOT-DA-21-011: Effects of smoking and vaping on the risk and outcome of COVID-19 infection (deadline Sept. 8, 2024)
• Added Feb. 19, 2021: Notice of Special Interest (NOSI) - NOT-DA-21-018: Long-Term Neurocognitive Consequences of COVID-19 in Individuals Living with HIV and Substance Use Disorders (deadline Sept. 8, 2024)
• Notice of Special Interest (NOSI) - NOT-DE-21-001: NIDCR Support for Research on the Physiological Involvement of Oral Cavity in Coronavirus Disease 2019 (COVID-19) (deadline May 8, 2023)
• Added Nov. 8, 2020: NOT-DA-20-084 - Notice of Special Interest (NOSI): Effects of smoking and vaping on the risk and outcome of COVID-19 infection (deadline Sept. 8, 2024)
• Added Oct. 26, 2020: NOT-HD-20-031 - Notice of Special Interest (NOSI): Research on Rehabilitation Needs Associated with the COVID-19 Pandemic (deadline May 8, 2023)
• Added Aug. 11, 2020: Urgent Phase I/II Clinical Trials to Repurpose Existing Therapeutic Agents to Treat COVID-19 Sequelae (U01 Clinical Trial Required) (rolling deadline and review)
• Added Aug. 3, 2020: PAR-20-256 (NIAID) - Limited Competition Emergency Awards: Shared Personal Protective Equipment Resources for COVID-19 Related Vaccine and Treatment Clinical Trials and Clinical Studies (S10 Clinical Trial Not Allowed) Eligibility is limited to recipients conducting COVID-related clinical research and clinical studies supported by NIAID's emergency appropriation provided by 'The Coronavirus Preparedness and Response Supplemental Appropriations Act, 2020' and 'The Coronavirus Aid, Relief and Economic Security (CARES) Act.' (deadline July 8, 2021)
• Added July 10, 2020: NOT-OD-20-129 - Notice of Special Interest (NOSI) regarding the Availability of Urgent Competitive Revisions and Administrative Supplements for Research on Coronavirus Disease 2019 (COVID-19) in Individuals with Down Syndrome for the INCLUDE Project (deadline July 12, 2021) Note: Applications for this initiative must be submitted electronically using one of the following target opportunities or their subsequent reissued equivalents: PA-18-591 or PA-18-935.
• Added July 10, 2020: NOT-AI-20-059 - NIAID Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions for Select Research Activities related to Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19). Applications in response to this NOSI must be submitted using the following targeted funding opportunity or subsequently reissued equivalent: PA-20-135. (deadline July 2, 2021)
• Added June 22, 2020: NIA Multi-site COVID-19 Related Clinical Trial Implementation Grant on Aging-Related Topics in at-risk Older Adult Populations (R01 Clinical Trial Required) (multiple deadlines through 2021)
• Updated May 19, 2020: NOT-AI-20-051 Notice of Special Interest (NOSI): Select Research Areas for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) (deadline Sept. 8, 2021)
• Added May 4, 2020: National Institute of Biomedical Imaging and Bioengineering Point-of-Care Technology Research Network Fast-Track Program for COVID-19 Test Development and Distribution: Innovative Technologies to Increase U.S. Capacity for COVID-19 Testing (NIBIB) (rolling deadline)
• Updated May 1, 2020: NOT-DK-20-026 Notice of Additional Activity Code Accepted for 'NOT-DK-20-018, Notice of Special Interest (NOSI): Availability of Urgent Competitive Revision Supplements on Coronavirus Disease 2019 (COVID-19) within the Mission of NIDDK'
• Added May 1, 2020: NOT-TR-20-018 Notice of Change in Eligibility and Activity Codes for NOT-TR-20-011, Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need
• Added April 27, 2020: NOT-AG-20-022 Notice of Special Interest (NOSI): NIA Availability of Administrative Supplements and Revision Supplements on Coronavirus Disease 2019 (COVID-19) (deadline May 1, 2021)
• Added April 27, 2020: NOT-CA-20-043 Notice of Special Interest (NOSI): National Cancer Institute Announcement regarding Availability of Competitive Revision SBIR/STTR Supplements on Coronavirus Disease 2019 (COVID-19)
• Added April 27, 2020: NOT-DC-20-006 Notice of Eligibility Change for NIDCD Urgent Competitive Revisions and Administrative Supplements for Research on COVID-19
• Added April 27, 2020: NOT-ES-20-015 Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19) (deadline May 4, 2021)
• Added April 27, 2020: NOT-ES-20-020 Notice of Special Interest (NOSI): NIEHS Support for Understanding the Impact of Environmental Exposures on Coronavirus Disease 2019 (COVID-19)
• Added April 27, 2020: NOT-MD-20-019 Notice of Special Interest (NOSI): Competitive and Administrative Supplements for the Impact of COVID-19 Outbreak on Minority Health and Health Disparities (deadline May 1, 2021)
• Added April 27, 2020: NOT-TR-20-017 Notice of Special Interest (NOSI) regarding the Availability of Emergency Competitive Revisions to Existing NIH Grants and Cooperative Agreements for Tissue Chips Research on the 2019 Novel Coronavirus (deadline Jan. 26, 2022)
• Added April 27, 2020: PA-18-935 Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional) (deadline Jan. 25, 2022)
• Added April 27, 2020: PA-20-135 Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement - Clinical Trial Optional) (deadline March 10, 2023)
• Updated April 7, 2020: NOT-TR-20-011 Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Program Applications to Address 2019 Novel Coronavirus (COVID-19) Public Heath Need (deadline July 10, 2021)

Resources

National Science Foundation: RAPID Research on Coronavirus (COVID-19)

Resources

Patient-Centered Outcomes Research Institute (PCORI)

USAID

Foundations

Note: Investigators with interest in foundation funding should contact Corporate and Foundation Relations before proceeding with any application process.

Other Funders

Note: Investigators with interest in corporate funding should contact Corporate and Foundation Relations before proceeding with any application process.

• Added Aug. 11, 2020: Social Science Research Council - Just Tech Covid-19 Rapid-Response Grants (rolling deadline)
• Added May 15, 2020: CETF and Rockefeller Philanthropy Advisors - COVID-19 Early Treatment Fund (rolling deadline)
• Added April 27, 2020: EdTech Hub, mEducation Alliance and Global Innovation Exchange Call for Ideas for EdTech Responses to Coronavirus (COVID-19) (rolling deadline)
• Added April 27, 2020: Rapidly Emerging Antiviral Drug Discovery Initiative (READDI)
• Added April 15, 2020: Allen Institute for AI COVID-19 Open Research Dataset Challenge (CORD-19)
• Added April 15, 2020: CoVent-19 Challenge: Innovate2Ventilate
• Added April 15, 2020: IBM: COVID-19 Call for Code
• Added April 15, 2020: XPRIZE Pandemic Alliance: Fight COVID-19
• Added April 13, 2020: Google Cloud Research Credits
• Added April 9, 2020: Emergent Ventures: Fast Funding for COVID-19 Science
• Added April 9, 2020: Joint European Disruptive Initiative (JEDI) - Billion Molecules Against COVID-19 JEDI Grand Challenge
• Added April 8, 2020: Pfizer COVID-19-Related Grant Requests
• Added March 26, 2020: Amazon AWS Diagnostic Development Initiative (DDI)

Learn more

For details, contact the Research Concierge Service at [email protected].

If you're having trouble accessing this content, or would like it in another format, please email the Penn State College of Medicine web department.

Public link

Please use the above public link if you want to share this noodl on another website.